PHARMA
Amerigen’s Mecobalamin Receives CFDA Approval
The CFDA approval of Mecobalamin marks Amerigen's entry into the Chinese generics market.
Hanmi Licenses Poziotinib To Luye Pharma
Luye acquires the rights to Poziotinib, Hanmi's pan-HER inhibitor for the treatment of cancer.
ZAI Lab Licenses Respiratory Disease Drugs From Sanofi
ZAI Lab has acquired the license for two pre-clinical drugs for chronic respiratory diseases.
PW Medtech Acquires Tianxinfu For US$130 Million
PW Medtech expands its capabilities in medical devices with the acquisition of Beijing Tianxinfu Medical Appliance Co.
Fosun Commits US$111 Million To Partnership With Public Hospital
The partnership between Fosun and Taizhou Muncipal Hospital will add approximately 2,000 new hospital beds to serve the residents of Taizhou.
Celltrion Files For FDA Approval For Biosimilar Drug
Celltrion predicts that it is one year away from approval for Remsima®, a biosimilar based on an originator drug from Janssen Biotech.
Fujitsu & NCKU Sign Big Data Platform MOU
The National Cheng Kung University and Fujitsu will develop a cloud computing platform for big data analysis in agriculture and genomics research.
Agreen Acquisition Enhances CBMG’s T-Cell Portfolio
China's Cellular Biomedicine Group acquires Agreen for US$3.38 million in cash in addition to stock units.
3SBio Licenses DiNonA’s Anti-Leukemia Treatment
3SBio and DiNonA will develop Leukotuximab, an anti JL-1 antibody indicated for the treatment of acute leukemia.
